ArticleInternational journal for numerical methods in biomedical engineering2026
Sequential Balloon Modeling for Robust Percutaneous Transluminal Angioplasty Simulation.
Article in International journal for numerical methods in biomedical engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Percutaneous transluminal angioplasty (PTA) is the standard treatment for atherosclerotic stenoses. It involves inflating a balloon inside the stenosis to create large deformations and achieve permanent enlargement of the lumen. PTA is typically performed prior to the placement of a stent as a preliminary reshaping procedure. Reshaping angioplasty as a standalone treatment emerged since the introduction of drug-coated balloons. PTA numerical simulation can help predict procedure outcomes, but faces challenges in cases of severe stenosis, notably due to balloon modeling strategy: exhaustive folded balloon models are computationally costly, while simplified balloon surface models experience excessive membrane strains which compromise simulation robustness. This work introduces a new strategy based on sequential balloon modeling (SBM). SBM aims to ensure the robustness of PTA finite element simulation, in cases of high inflation range, for example, PTA on severe stenosis. Such condition results in a high gain from the initial to the maximal balloon diameter, causing simulation divergence due to excessive element deformation, combined with contact. SBM limits the deformation experienced by the balloon by dividing the whole inflation in several steps, each with a limited amount of diametral gain for the balloon. The angioplasty balloon is replaced by several balloons, modeled as unfolded, which come into play sequentially. These artificial balloons aim to dilate the stenosed artery progressively and to reproduce the pressure-diameter curve of the modeled balloon as described by the manufacturer datasheet. In this work, SBM is combined with parametric stenosis modeling to build a robust and versatile model for estimating the permanent set after reshaping. To demonstrate the robustness of this strategy, we first investigate parametric single-stenosis models to assess the influence of geometric parameters and plaque type on post-PTA results. We focus on severe degrees of stenosis and large artery calibers, which are rarely studied in the literature. We then illustrate how this strategy can be used to replicate a complex, patient-specific iliac artery stenosis case by combining single-stenosis models. The SBM strategy demonstrates promising results in terms of versatility and robustness, paving the way for further PTA simulation validation and mechanical insights to optimize treatment strategies for severe stenosis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.